Robeco Institutional Asset Management B.V. Gilead Sciences, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$60.3 Billion
Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 3,742,656 shares of GILD stock, worth $435 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

3,742,656

Previous 3,325,419 12.55%

Holding current value

$435 Million

Previous $373 Million 11.36%

% of portfolio

0.69%

Previous 0.74%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$96.91 - $113.0 $40.4 Million - $47.1 Million	417,237 Added 12.55%	3,742,656 $415 Million
Q1 2025 Apr 23, 2025	SELL	$89.14 - $117.41 $8.73 Million - $11.5 Million	-97,963 Reduced 2.86%	3,325,419 $373 Million
Q4 2024 Jan 22, 2025	SELL	$83.95 - $97.9 $480,697 - $560,575	-5,726 Reduced 0.17%	3,423,382 $316 Million
Q3 2024 Oct 29, 2024	SELL	$66.59 - $83.99 $3.86 Million - $4.86 Million	-57,915 Reduced 1.66%	3,429,108 $287 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $6.07 Million - $7 Million	-96,067 Reduced 2.68%	3,487,023 $239 Million
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $1.17 Million - $1.42 Million	-16,317 Reduced 0.45%	3,583,090 $262 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $122 Million - $139 Million	1,668,085 Added 86.37%	3,599,407 $292 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $133 Million - $151 Million	-1,813,174 Reduced 48.42%	1,931,322 $3.6 Billion
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $8.23 Million - $8.98 Million	-111,284 Reduced 2.89%	3,744,496 $281 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $645,628 - $736,429	-8,494 Reduced 0.22%	3,855,780 $297 Million
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $15.2 Million - $17.3 Million	196,051 Added 5.34%	3,864,274 $321 Million
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $1.71 Million - $2.45 Million	27,383 Added 0.75%	3,668,223 $315 Million
Q3 2022 Dec 01, 2022	BUY	$59.54 - $68.01 $2.35 Million - $2.68 Million	39,469 Added 1.1%	3,640,840 $225 Million
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $2.35 Million - $2.68 Million	39,469 Added 1.1%	3,640,840 $225 Million
Q2 2022 Dec 01, 2022	SELL	$57.72 - $65.01 $5.86 Million - $6.6 Million	-101,560 Reduced 2.74%	3,601,371 $223 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $5.86 Million - $6.6 Million	-101,560 Reduced 2.74%	3,601,371 $223 Million
Q1 2022 Dec 01, 2022	BUY	$57.92 - $72.58 $10.3 Million - $12.9 Million	177,799 Added 5.04%	3,702,931 $220 Million
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $10.3 Million - $12.9 Million	177,799 Added 5.04%	3,702,931 $220 Million
Q4 2021 Dec 01, 2022	BUY	$64.88 - $73.64 $99.1 Million - $113 Million	1,528,101 Added 76.52%	3,525,132 $256 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $99.1 Million - $113 Million	1,528,101 Added 76.52%	3,525,132 $256 Million
Q3 2021 Dec 01, 2022	SELL	$67.69 - $73.03 $8.49 Million - $9.16 Million	-125,474 Reduced 5.91%	1,997,031 $139 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $8.49 Million - $9.16 Million	-125,474 Reduced 5.91%	1,997,031 $139 Million
Q2 2021 Dec 01, 2022	BUY	$63.47 - $69.35 $4.8 Million - $5.25 Million	75,692 Added 3.7%	2,122,505 $146 Million
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $4.8 Million - $5.25 Million	75,692 Added 3.7%	2,122,505 $146 Million
Q1 2021 Dec 01, 2022	SELL	$60.0 - $68.46 $95.6 Million - $109 Million	-1,594,027 Reduced 43.78%	2,046,813 $132 Million
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $1.66 Million - $1.9 Million	-27,684 Reduced 1.33%	2,046,813 $132 Million
Q4 2020 Dec 01, 2022	SELL	$56.65 - $64.55 $88.7 Million - $101 Million	-1,566,343 Reduced 43.02%	2,074,497 $121 Million
Q4 2020 Jan 28, 2021	BUY	$56.65 - $64.55 $4.21 Million - $4.8 Million	74,318 Added 3.72%	2,074,497 $121 Million
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $35.9 Million - $45.2 Million	578,454 Added 40.69%	2,000,179 $126 Million
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $11 Million - $12.8 Million	152,290 Added 12.0%	1,421,725 $109 Million
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $17.3 Million - $22.1 Million	-275,926 Reduced 17.86%	1,269,435 $94.9 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $4.6 Million - $5.06 Million	74,637 Added 5.07%	1,545,361 $100 Million
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $6.64 Million - $7.33 Million	106,258 Added 7.79%	1,470,724 $93.2 Million
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $414,714 - $465,054	-6,703 Reduced 0.49%	1,364,466 $92.2 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $16.3 Million - $18.3 Million	261,074 Added 23.52%	1,371,169 $89.1 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $1.91 Million - $2.49 Million	31,481 Added 2.92%	1,110,095 $69.3 Million
Q3 2018 Oct 31, 2018	BUY	$71.28 - $78.92 $82,684 - $91,547	1,160 Added 0.11%	1,078,614 $83.3 Million
Q3 2018 Oct 25, 2018	BUY	$71.28 - $78.92 $8.08 Million - $8.95 Million	113,365 Added 11.76%	1,077,454 $83.2 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $2.75 Million - $3.21 Million	42,385 Added 4.6%	964,089 $68.3 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $11.9 Million - $14.5 Million	163,262 Added 21.53%	921,704 $69.5 Million
Q4 2017 Jan 25, 2018	BUY	$71.15 - $83.52 $20.7 Million - $24.3 Million	290,556 Added 62.1%	758,442 $54.3 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $1.23 Million - $1.46 Million	17,059 Added 3.78%	467,886 $37.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	74,211 Added 19.7%	450,827 $31.9 Million
Q1 2017 Jan 19, 2021	BUY	N/A	376,616	376,616 $25.6 Million

Others Institutions Holding GILD

# of Institutions

2,294

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $146B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Gilead Sciences, Inc. Transaction History